 Axonics Modulation Technologies, Inc. NASDAQ: AXNX, a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation SNM devices for the treatment of urinary and bowel dysfunction, will report financial results for the second quarter of 2020 after the market closes on Thursday, August 6, 2020. 